18:1 Caproylamine PE
| Catalog Number | BL-M000628 |
| CAS Number | 110796-31-1 |
| Description | 18:1 Caproylamine PE exhibits promising efficacy in pharmaceutical applications, particularly in addressing complex neurological conditions and malignancies like breast cancer. Its role as a therapeutic modality in Alzheimer's disease is of particular interest, highlighting its potential as a multifaceted treatment option for intricate medical conditions. |
 | |
| IUPAC Name | 2-(6-azaniumylhexanoylamino)ethyl [(2R)-2,3-bis[[(Z)-octadec-9-enoyl]oxy]propyl] phosphate |
| Synonyms | 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine-N-(hexanoylamine); 1,2-di-(9Z-octadecenoyl)-sn-glycero-3-phosphoethanolamine-N-(hexanoylamine) |
| Molecular Weight | 857.19 |
| Molecular Formula | C47H89N2O9P |
| Purity | >99% |
| Appearance | Powder |
| Shelf Life | 1 Year |
| Storage | Store at -20°C |
| Percent Composition | C 65.86%, H 10.47%, N 3.27%, O 16.80%, P 3.61% |
| Canonical SMILES | CCCCCCCCC=CCCCCCCCC(=O)OCC(COP(=O)([O-])OCCNC(=O)CCCCC[NH3+])OC(=O)CCCCCCCC=CCCCCCCCC |
| InChI | InChI=1S/C47H89N2O9P/c1-3-5-7-9-11-13-15-17-19-21-23-25-27-29-33-37-46(51)55-42-44(43-57-59(53,54)56-41-40-49-45(50)36-32-31-35-39-48)58-47(52)38-34-30-28-26-24-22-20-18-16-14-12-10-8-6-4-2/h17-20,44H,3-16,21-43,48H2,1-2H3,(H,49,50)(H,53,54)/b19-17-,20-18-/t44-/m1/s1 |
| InChI Key | OVCGTEBXOCFVEO-OHRCZFALSA-N |
※ Please be kindly noted products are not for therapeutic use. We do not sell to patients.
Related Products
Online Inquiry